Terug
76
Dagbereik
€ 33,49
€ 34,76
52-Weeksbereik
€ 24,10
€ 57,99
Volume
1.180.232
50D / 200D Gem.
€ 45,69
/
€ 39,68
Vorige Slotkoers
€ 34,71
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,7 | 0,3 |
| P/B | 3,6 | 2,9 |
| ROE % | -40,2 | 3,7 |
| Net Margin % | -6046,2 | 3,8 |
| Rev Growth 5Y % | 63,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 94,71
+175.6%
Low: € 67,00
High: € 143,00
Forward WPA
-€ 4,77
Omzet Sch.
62 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,93
€ 3,44 – € 6,33
|
1,6 B | 1 |
| FY2029 |
€ 0,95
€ 0,67 – € 1,22
|
930 M | 1 |
| FY2028 |
-€ 2,47
-€ 3,72 – -€ 0,99
|
420 M | 5 |
Belangrijkste Punten
Revenue grew 63,46% annually over 5 years — strong growth
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -383,68M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 577,25%
Capital intensive — 74,87% of revenue goes to capex
Groei
Revenue Growth (5Y)
63,46%
Revenue (1Y)640,71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-40,17%
ROIC-37,24%
Net Margin-6046,22%
Op. Margin-6714,77%
Veiligheid
Debt / Equity
0,05
Current Ratio12,32
Interest Coverage0,00
Waardering
P/E Ratio
-7,73
P/B Ratio3,63
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 640,71% | Revenue Growth (3Y) | 38,48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,70M | Net Income (TTM) | -465,32M |
| ROE | -40,17% | ROA | -40,98% |
| Gross Margin | 35,47% | Operating Margin | -6714,77% |
| Net Margin | -6046,22% | Free Cash Flow (TTM) | -383,68M |
| ROIC | -37,24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 12,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,73 | P/B Ratio | 3,63 |
| P/S Ratio | 467,61 | PEG Ratio | -0,28 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,60B | Enterprise Value | 3,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,70M | 1,04M | 4,01M | 4,74M | 1,08M |
| Net Income | -465,32M | -298,41M | -214,53M | -163,92M | -107,64M |
| EPS (Diluted) | -4,95 | -3,69 | -3,69 | -3,15 | -2,80 |
| Gross Profit | 2,73M | 1,04M | 4,01M | 4,74M | 1,08M |
| Operating Income | -516,77M | -338,85M | -222,61M | -167,88M | -107,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,14B | 1,43B | 635,35M | 352,18M | 351,02M |
| Total Liabilities | 143,41M | 109,79M | 96,25M | 35,85M | 19,07M |
| Shareholders' Equity | 992,08M | 1,32B | 539,11M | 316,33M | 331,94M |
| Total Debt | 48,54M | 51,72M | 51,73M | 3,08M | 3,07M |
| Cash & Equivalents | 101,54M | 264,55M | 54,90M | 32,67M | 200,70M |
| Current Assets | 1,05B | 1,38B | 574,15M | 345,18M | 344,72M |
| Current Liabilities | 85,07M | 59,68M | 43,94M | 27,72M | 16,00M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#14 of 76
Recente Activiteit
Ingestapt
Capital Heavy Grower
Mar 24, 2026